Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huang-Chi-Wu-Wu-Tang in Intracranial Arterial Stenosis
NCT01553643Phase 4
Key facts
- Status
- Unknown
- Start
- Jan 2010
- Primary completion
- Nov 2012
- Countries
- 1
- Sponsor
- China Medical University Hospital
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Conditions
- Intracranial arterial stenosis (ICAS)
01
Overview
Phase 4, randomised, double-blind trial in Intracranial arterial stenosis (ICAS) comparing Huang-Chi-Wu-Wu-Tang with Placebo (2 arms). Primary endpoint: Improvement hemodynamics at intracranial vessels in the M1 segment of middle cerebral artery (MCA) or basilar artery (BA) at 3 years. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Huang-Chi-Wu-Wu-Tang
Huang-Chi-Wu-Wu-Tang 3g BID
Placebo
Placebo 3g BID
03
Who it enrols
Patients >40 years old with intracranial arterial stenosis (MCA M1 or BA stenosis 50-99%) confirmed by Transcranial Doppler Sonography. Excludes patients with major diseases such as MI, heart failure, COPD, liver or renal failure, and pregnancy/breast-feeding.
04
Endpoints
Primary
Improvement hemodynamics at intracranial vessels in the M1 segment of middle cerebral artery (MCA) or basilar artery (BA)
Beyond the preview
Go deeper on NCT01553643.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553643.